376 related articles for article (PubMed ID: 29034895)
1. Generation of induced pluripotent stem cell (iPSC) line from Charcot-Marie-Tooth disease patient with MPZ mutation (CMT1B).
Son D; Kang PJ; Yun W; You S
Stem Cell Res; 2017 Oct; 24():5-7. PubMed ID: 29034895
[TBL] [Abstract][Full Text] [Related]
2. Generation of a human Charcot-Marie-Tooth disease type 1B (CMT1B) iPSC line, ZJUCHi001-A, with a mutation of c.292C>T in MPZ.
Xu J; Wang Y; He J; Xia W; Zou Y; Ruan W; Lou Q; Li Y; Li H; Chen W
Stem Cell Res; 2019 Mar; 35():101407. PubMed ID: 30785048
[TBL] [Abstract][Full Text] [Related]
3. Generation of induced pluripotent stem cell (iPSC) line from a 36-year-old Charcot-Marie-Tooth disease patient with GJB1 mutation (CMTX).
Son D; Kang PJ; Yun W; You S
Stem Cell Res; 2017 May; 21():9-12. PubMed ID: 28677541
[TBL] [Abstract][Full Text] [Related]
4. Charcot-Marie-Tooth 1B caused by expansion of a familial myelin protein zero (MPZ) gene duplication.
Speevak MD; Farrell SA
Eur J Med Genet; 2013 Oct; 56(10):566-9. PubMed ID: 23811036
[TBL] [Abstract][Full Text] [Related]
5. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
6. Generation of a human induced pluripotent stem cell (iPSC) line (JUCTCi019-A) from a patient with Charcot-Marie-Tooth disease type 2A2 (CMT2A2) due to a heterozygous missense substitution c.2119C > T (p.Arg707Trp) in MFN2 gene.
Ababneh NA; Barham R; Al-Kurdi B; Ali D; Hadidi SA; A Ismail M; Muamar ASH; Abdulelah AA; Madadha A; Sallam M; Hassona Y; Masri A; Awidi A
Stem Cell Res; 2022 Jul; 62():102786. PubMed ID: 35468369
[TBL] [Abstract][Full Text] [Related]
7. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
8. Focally folded myelin in Charcot-Marie-Tooth type 1B disease is associated with Asn131Lys mutation in myelin protein zero gene: short report.
Kochański A; Drac H; Jedrzejowska H; Hausmanowa-Petrusewicz I
Eur J Neurol; 2003 Sep; 10(5):547-9. PubMed ID: 12940837
[TBL] [Abstract][Full Text] [Related]
9. Generation of induced pluripotent stem cell line, ZJUCHi002-A, from Charcot-Marie-Tooth disease type 2A (CMT2A) patient with a mutation of c.752C>T in MFN2.
Xu J; Fu Y; Xia W; He J; Zou Y; Ruan W; Lou Q; Li Y; Pan J; Li H; Chen W
Stem Cell Res; 2019 Apr; 36():101411. PubMed ID: 30807887
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic description of a family with Charcot-Marie-Tooth disease type 1B from a transmembrane MPZ mutation.
Eggers SD; Keswani SC; Melli G; Cornblath DR
Muscle Nerve; 2004 Jun; 29(6):867-9. PubMed ID: 15170620
[TBL] [Abstract][Full Text] [Related]
11. A novel MPZ mutation in Charcot-Marie-Tooth disease type 1B with focally folded myelin and multiple entrapment neuropathies.
Iida M; Koike H; Ando T; Sugiura M; Yamamoto M; Tanaka F; Sobue G
Neuromuscul Disord; 2012 Feb; 22(2):166-9. PubMed ID: 21940171
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the Myelin Protein Zero result in a spectrum of Charcot-Marie-Tooth phenotypes.
Kochański A
Acta Myol; 2004 May; 23(1):6-9. PubMed ID: 15298082
[TBL] [Abstract][Full Text] [Related]
13. Myelin protein zero gene mutated in Charcot-Marie-tooth type 1B patients.
Su Y; Brooks DG; Li L; Lepercq J; Trofatter JA; Ravetch JV; Lebo RV
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10856-60. PubMed ID: 7504284
[TBL] [Abstract][Full Text] [Related]
14. Screening of the myelin protein zero gene in patients with Charcot-Marie-Tooth disease.
Nowakowski A; Kochański A
Acta Biochim Pol; 2004; 51(1):273-80. PubMed ID: 15094849
[TBL] [Abstract][Full Text] [Related]
15. A novel synonymous mutation in the MPZ gene causing an aberrant splicing pattern and Charcot-Marie-Tooth disease type 1b.
Corrado L; Magri S; Bagarotti A; Carecchio M; Piscosquito G; Pareyson D; Varrasi C; Vecchio D; Zonta A; Cantello R; Taroni F; D'Alfonso S
Neuromuscul Disord; 2016 Aug; 26(8):516-20. PubMed ID: 27344971
[TBL] [Abstract][Full Text] [Related]
16. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11.
Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
Stem Cell Res; 2016 May; 16(3):553-6. PubMed ID: 27346190
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of large myelin protein zero leads to Charcot-Marie-Tooth disease-like neuropathy in mice.
Otani Y; Ohno N; Cui J; Yamaguchi Y; Baba H
Commun Biol; 2020 Mar; 3(1):121. PubMed ID: 32170207
[TBL] [Abstract][Full Text] [Related]
18. Episomal plasmid-based generation of an iPSC line from an 83-year-old individual carrying the APOE4/4 genotype: i10984.
Zulfiqar S; Fritz B; Nieweg K
Stem Cell Res; 2016 Nov; 17(3):523-525. PubMed ID: 27789402
[TBL] [Abstract][Full Text] [Related]
19. Generation of a disease-specific iPS cell line derived from a patient with Charcot-Marie-Tooth type 2K lacking functional GDAP1 gene.
Martí S; León M; Orellana C; Prieto J; Ponsoda X; López-García C; Vílchez JJ; Sevilla T; Torres J
Stem Cell Res; 2017 Jan; 18():1-4. PubMed ID: 28395795
[TBL] [Abstract][Full Text] [Related]
20. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.B11.
Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
Stem Cell Res; 2016 May; 16(3):589-92. PubMed ID: 27346191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
